

Canadian Ebola vaccine: safety and immunogenicity of the VSV-ZEBOV vaccine
Jun 19, 2017
12:15
Dr. May ElSherif discusses the randomized control trial of a Canadian Ebola vaccine that was developed at the National Microbiology Laboratory in Winnipeg, Canada. Dr. ElSherif is an international medical graduate specialized in medical microbiology and research associate at the Dalhousie University Canadian Center for Vaccinology in Halifax, Nova Scotia. Dr. ElSherif and her co-authors recently published the results of their trial in the CMAJ.Full research article: www.cmaj.ca/lookup/doi/10.1503/cmaj.170074To request a transcript of this podcast, contact cmajgroup@cmaj.caSubscribe to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions